The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 01, 2015
Filed:
Aug. 01, 2014
Applicant:
Replicor Inc, Montreal, CA;
Inventors:
Michel Bazinet, Montreal, CA;
Andrew Vaillant, Roxboro, CA;
Assignee:
Other;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); A61K 31/519 (2006.01); A61K 39/42 (2006.01); A61K 31/7088 (2006.01); A61K 38/22 (2006.01); A61K 31/566 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1131 (2013.01); A61K 31/519 (2013.01); A61K 31/566 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 31/7105 (2013.01); A61K 38/212 (2013.01); A61K 38/215 (2013.01); A61K 38/217 (2013.01); A61K 38/2292 (2013.01); A61K 39/42 (2013.01); A61K 45/06 (2013.01);
Abstract
It is disclosed a method for the treatment of hepatitis B (HBV) infection or HBV/hepatitis D (HDV) co-infection, the method comprising administering to a subject in need of treatment a first pharmaceutically acceptable agent that removes the hepatitis B surface antigen from the blood and a second pharmaceutically acceptable agent which stimulates immune function.